These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 407684)

  • 1. Passive immunization of mice against Trypanosoma cruzi using convalescent mouse serum.
    McHardy N
    Tropenmed Parasitol; 1977 Jun; 28(2):195-201. PubMed ID: 407684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of mice against Trypanosoma cruzi: the effect of chemical treatment or immune serum on an epimastigote vaccine.
    McHardy N
    Tropenmed Parasitol; 1978 Jun; 29(2):215-22. PubMed ID: 209592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice.
    Kierszenbaum F; Howard JG
    J Immunol; 1976 May; 116(5):1208-11. PubMed ID: 818311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of specific antibodies in Trypanosoma cruzi infections.
    Krettli AU; Brener Z
    J Immunol; 1976 Mar; 116(3):755-60. PubMed ID: 815433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
    Introini MV; Basso B; Moretti E
    Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive protection of mice against infection with Trypanosoma cruzi with plasma: the use of blood- and vector bug-derived trypomastigote challenge.
    McHardy N
    Parasitology; 1980 Jun; 80(3):471-8. PubMed ID: 6771737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi].
    Basombrio MA; Mora MC; Segura MA
    Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: the fate of bloodstream trypomastigote, amastigote, metacyclic trypomastigote and epimastigote forms in the peritoneal macrophages of immune and non-immune mice in vivo.
    Burger E; Lay WH; Hypolito LV; Fernandes JF
    Acta Trop; 1982 Jun; 39(2):111-22. PubMed ID: 6126093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi.
    Ruiz AM; Esteva M; Cabeza Meckert P; Laguens RP; Segura EL
    Acta Trop; 1985 Dec; 42(4):299-309. PubMed ID: 2868632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against Trypanosoma cruzi using killed antigens and with saponin as adjuvant.
    Neal RA; Johnson P
    Acta Trop; 1977 Mar; 34(1):87-96. PubMed ID: 16471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of mice against Trypanosoma cruzi. The effect of size of dose, and route of injection, of immunizing and challenge inocula.
    McHardy H
    Tropenmed Parasitol; 1977 Mar; 28(1):11-6. PubMed ID: 404742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of Trypanosoma cruzi to blood clearance induced by acute-phase immune mouse serum.
    Alvarez JM; Marinho CR; Oshima A; Guimaraes L; Menezes H
    J Parasitol; 1992 Dec; 78(6):1074-7. PubMed ID: 1491301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain specific protective immunity against Trypanosoma cruzi.
    Kloetzel JK; Lafaille JJ
    J Parasitol; 1983 Apr; 69(2):267-70. PubMed ID: 6406657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 75Se-methionine labelled Trypanosoma cruzi blood trypomastigotes: opsonization by chronic infection serum facilitates killing in spleen and liver.
    Scott MT; Moyes L
    Clin Exp Immunol; 1982 Jun; 48(3):754-7. PubMed ID: 6811174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.
    Pinge-Filho P; Peron JP; de Moura TR; Menolli RA; Graça VK; Estevão D; Tadokoro CE; Jankevicius JV; Rizzo LV
    Immunol Lett; 2005 Jan; 96(2):283-90. PubMed ID: 15585334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kinetics of the humoral immune response in mice immunized against and inoculated with Trypanosoma cruzi].
    Licón-Trillo A; Pérez-Reyes R
    Rev Latinoam Microbiol; 1994; 36(2):119-25. PubMed ID: 7973179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.